Children with recurrent strep throat whose tonsils have not been removed are over three times more likely to develop subsequent episodes of strep throat than children who undergo tonsillectomy, according to a Mayo Clinic study published in the Nov. 2 issue of Laryngoscope.
An educational intervention program for parents of infants born prematurely that is implemented early in the Neonatal Intensive Care Unit (NICU) can reduce parental stress, depression and anxiety, enhance parent-infant interactions, and reduce hospital length of stay, according to a study led by Dr. Bernadette Melnyk, Dean and Distinguished Foundation Professor in Nursing at Arizona State University College of Nursing & Healthcare Innovation, Phoenix.
New plans for faster, better and more convenient care for the millions of people who suffer from bone and joint ailments such as arthritis, back pain and fractures were announced today by Health Minister Andy Burnham.
Researchers have used a single compound to increase the lifespan of obese mice, and found that the drug reversed nearly all of the changes in gene expression patterns found in mice on high calorie diets–some of which are associated with diabetes, heart disease, and other significant diseases related to obesity. The research, led by investigators at Harvard Medical School and the National Institute on Aging, is the first time that the small molecule resveratrol has been shown to offer survival benefits in a mammal. The study is reported in the November 1 advanced online edition of Nature.
This is a petition to urge the Transportation Security Administration to consider breast milk to be a life sustaining and supporting body fluid for babies. This means that mothers would be allowed to carry pumped breast milk in the cabin of airplanes in any amount whether traveling with or without their infants.
Pharmion Corporation (Nasdaq: PHRM) announced today the enrollment of the first patient in AVIDA(TM), a registry for patients treated with Vidaza(R) (azacitidine for injectable suspension). Vidaza was approved in May 2004 for the treatment of all five French-American-British (FAB) subtypes of myelodysplastic syndromes (MDS): refractory anemia (RA) or refractory anemia with ringed sideroblasts (RARS) if accompanied by neutropenia or thrombocytopenia or requiring transfusions; refractory anemia with excess blasts (RAEB), refractory anemia with excess blasts in transformation (RAEB-T), and chronic myelomonocytic leukemia (CMMoL). Myelodysplastic syndromes are a serious and life-threatening group of diseases in which the bone marrow does not function normally, resulting in the production of malformed or immature blood cells.
For years researchers have been trying to understand how a few HIV-infected patients naturally defeat a virus that otherwise overwhelms the immune system. Last year, a research team at the University of Rochester Medical Center confirmed that such patients, called long-term non-progressors, maintain higher than normal levels of the enzyme called APOBEC-3G (A3G) in their white blood cells, which function to stave off infections. Now, the same group has teamed up with a structural biologist to provide the first look at the A3G structure. Such information represents an early step toward the design of a new class of drugs that could afford to all the same natural protection enjoyed by few, according to a study published today in The Journal of Biological Chemistry.
A study published in the journal “Progress in Cardiovascular Diseases” refutes the frequently repeated claims that a comprehensive salt reduction would not produce any overall health benefits, or would even increase diseases and shorten the life-span.
An educational intervention program for parents of infants born prematurely that is implemented early in the Neonatal Intensive Care Unit (NICU) can reduce parental stress, depression and anxiety, enhance parent-infant interactions, and reduce hospital length of stay, according to a study led by Dr. Bernadette Melnyk, Dean and Distinguished Foundation Professor in Nursing at Arizona State University College of Nursing & Healthcare Innovation, Phoenix.
More than two-thirds of people who suffer from major depression can become symptom-free if they are willing to work with their doctors and try various treatments to determine which work best for them, which may involve taking different antidepressants or adding cognitive therapy to the mix.